Published in J Pharmacol Exp Ther on December 01, 1982
Protection against chemical-induced lung injury by inhibition of pulmonary cytochrome P-450. Environ Health Perspect (1990) 0.80
A review of environmental and occupational exposure to xylene and its health concerns. EXCLI J (2015) 0.75
Regulation of JNK signaling by GSTp. EMBO J (1999) 4.06
Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine. Br J Cancer (2010) 3.25
Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem (2000) 3.15
Nucleotide sequence of the L-arabinose regulatory region of Escherichia coli K12. J Biol Chem (1978) 2.88
Thyroid-stimulating immunoglobulins in Graves' disease. Lancet (1974) 2.84
Carbimazole and the autoimmune response in Graves' disease. N Engl J Med (1980) 2.62
Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet (1975) 2.57
The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochem Soc Trans (2000) 2.40
Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Natl Acad Sci U S A (1998) 2.32
Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis (1997) 2.05
CDtool-an integrated software package for circular dichroism spectroscopic data processing, analysis, and archiving. Anal Biochem (2004) 1.96
Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Nature (1990) 1.96
Nomenclature for human CYP2D6 alleles. Pharmacogenetics (1996) 1.91
Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis (1993) 1.84
Dermoid cyst in the floor of the mouth. Review of the literature and case reports. Oral Surg Oral Med Oral Pathol (1994) 1.83
Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3. Biochem Pharmacol (1998) 1.80
An enzyme-linked immunoassay for thyroid microsomal antibodies. J Immunol Methods (1982) 1.79
Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis (1997) 1.78
Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol (1994) 1.76
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate. J Bone Miner Res (2001) 1.76
The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut (2005) 1.73
Histology by magnetic resonance microscopy. Magn Reson Q (1993) 1.71
Genetic analysis of the human cytochrome P450 CYP2C9 locus. Pharmacogenetics (1996) 1.67
Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. Dev Dyn (2000) 1.67
Alteration in connexin 43 gap junction gene dosage impairs conotruncal heart development. Dev Biol (1998) 1.64
Molecular mechanisms of drug resistance. Biochem J (1990) 1.56
Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther (2001) 1.56
Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis (2003) 1.54
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther (2001) 1.54
Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis (1991) 1.53
Thyroid-autoantibody synthesis by Hashimoto thyroid lymphocytes. Lancet (1979) 1.52
Immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in autoimmune adrenal diseases. Clin Chem (1995) 1.51
Hepatic fibrosis and cirrhosis after chronic administration of alcohol and "low-dose" carbon tetrachloride vapor in the rat. Hepatology (1991) 1.51
Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains. Proc Natl Acad Sci U S A (1994) 1.51
CYP2D6 genotyping and the association with lung cancer susceptibility. Pharmacogenetics (1994) 1.50
Aryl hydrocarbon receptor-dependent induction of cyp1a1 by bilirubin in mouse hepatoma hepa 1c1c7 cells. Mol Pharmacol (1997) 1.49
Alternative splicing in the human cytochrome P450IIB6 gene generates a high level of aberrant messages. Nucleic Acids Res (1989) 1.48
Cloning of a human autoimmune response: preparation and sequencing of a human anti-thyroglobulin autoantibody using a combinatorial approach. Autoimmunity (1992) 1.47
Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int J Cancer (1987) 1.47
Lymphocyte and monocyte subset changes during cardiopulmonary bypass: effects of aging and gender. J Lab Clin Med (1997) 1.46
Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects. Carcinogenesis (1988) 1.45
The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages. J Biol Chem (2001) 1.44
Amplification and increased expression of alpha class glutathione S-transferase-encoding genes associated with resistance to nitrogen mustards. Proc Natl Acad Sci U S A (1988) 1.43
Cytodifferentiation of the nonciliated bronchiolar epithelial (Clara) cell during rabbit lung maturation: an ultrastructural and morphometric study. Am J Anat (1983) 1.43
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med Res Rev (2001) 1.43
Ketamine as an adjunct to morphine in the treatment of pain. Pain (1995) 1.42
An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol (Oxf) (1982) 1.42
Biomechanical evaluation of new fixation devices for mandibular angle fractures. Int J Oral Maxillofac Surg (1997) 1.41
Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest (1995) 1.40
Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi. Proc Natl Acad Sci U S A (2000) 1.40
Cricoid pressure training: how useful are descriptions of force? Anaesth Intensive Care (2003) 1.39
Variables of patient-controlled analgesia 4: the relevance of bolus dose size to supplement a background infusion. Anaesthesia (1990) 1.39
Increase of surface Ia-like antigen expression on human monocytes independent of antigenic stimuli. J Immunol (1981) 1.39
Analysis of variance in the study of drug interactions. Pain (1993) 1.38
Dynamics of leukocyte-platelet adhesion in whole blood. Blood (1991) 1.38
The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica (1978) 1.37
Msp-1 polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res (1987) 1.37
Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood (1992) 1.36
Enterococcal superinfection and colonization with aztreonam therapy. Antimicrob Agents Chemother (1984) 1.35
Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest (2000) 1.34
Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes. I. Lymphocyte markers and response to pokeweed mitogen. Clin Exp Immunol (1983) 1.34
Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS. J Clin Microbiol (1993) 1.33
The interaction of the long-acting thyroid stimulator (LATS) with thyroid tissue in vitro. J Endocrinol (1970) 1.30
Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues. Carcinogenesis (1990) 1.28
Prediction of relapse in hyperthyroid Graves' disease. Lancet (1980) 1.27
Measurement of thyrotropin receptor antibodies. Methods Enzymol (1981) 1.26
Metabolic polymorphisms and cancer susceptibility. Cancer Surv (1995) 1.26
The reduction of polyhalogenated methanes by liver microsomal cytochrome P450. Mol Pharmacol (1977) 1.25
Human microsomal glutathione S-transferase. Its involvement in the conjugation of hexachlorobuta-1,3-diene with glutathione. Biochem J (1989) 1.24
Diagnosis of acute appendicitis: value of unenhanced CT. AJR Am J Roentgenol (1993) 1.24
Bronchial tree penetration of antibiotics. Chest (1983) 1.22
Thyroid stimulators in health and disease. Clin Endocrinol (Oxf) (1975) 1.21
The role of glutathione-dependent enzymes in drug resistance. Pharmacol Ther (1991) 1.21
Variables of patient-controlled analgesia. 2. Concurrent infusion. Anaesthesia (1989) 1.21
Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Chem (1989) 1.20
Lymphocyte adhesion-dependent calcium signaling in human endothelial cells. J Cell Biol (1995) 1.20
Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood (1991) 1.20
Characterization, localization and regulation of a novel phenobarbital-inducible form of cytochrome P450, compared with three further P450-isoenzymes, NADPH P450-reductase, glutathione transferases and microsomal epoxide hydrolase. Carcinogenesis (1984) 1.20
Phenotype of recovering lymphoid cell populations after marrow transplantation. J Exp Med (1985) 1.20
Chemical depletion of glutathione in vivo. Methods Enzymol (1981) 1.20
Cloning and characterization of a novel human dual flavin reductase. J Biol Chem (2000) 1.18
Pharmacokinetics of fentanyl in lumbar and cervical CSF following lumbar epidural and intravenous administration. Pain (1989) 1.18
Caffeine promotes ethanol drinking in rats. Examination using a limited-access free choice paradigm. Alcohol (2000) 1.17
Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil. Br J Anaesth (1992) 1.16
Grapefruit juice-terfenadine single-dose interaction: magnitude, mechanism, and relevance. Clin Pharmacol Ther (1997) 1.16
Expression of human glutathione S-transferases in Saccharomyces cerevisiae confers resistance to the anticancer drugs adriamycin and chlorambucil. Biochem J (1990) 1.16
Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver. Proc Natl Acad Sci U S A (1990) 1.16
The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation. J Exp Med (1996) 1.16
Immobilized IL-8 triggers progressive activation of neutrophils rolling in vitro on P-selectin and intercellular adhesion molecule-1. J Immunol (2001) 1.15
Bidirectional effects of GABAergic agonists and antagonists on maintenance of voluntary ethanol intake in rats. Pharmacol Biochem Behav (1993) 1.15
Transient neonatal hyperthyrotrophinaemia: a serum abnormality due to transplacentally acquired antibody to thyroid stimulating hormone. Br Med J (Clin Res Ed) (1983) 1.15
Placental markers of human exposure to polychlorinated biphenyls and polychlorinated dibenzofurans. Environ Health Perspect (1987) 1.14
Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochem J (1990) 1.14
Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation. J Cell Sci (1996) 1.14
Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxins. Int J Radiat Oncol Biol Phys (1989) 1.13
Kinetics of immunoglobulin production by cultured human peripheral blood lymphocytes. J Immunol Methods (1978) 1.13
Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains. Biochemistry (2001) 1.13